Metabolomics and atherosclerosis

Sascha N. Goonewardena, Lisa E. Prevette, Ankit Desai

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Metabolites reflect the dynamic processes underlying cellular homeostasis. Recent advances in analytical chemistry and molecular biology have set the stage for metabolite profiling to help us understand complex molecular processes and physiology. Metabolomics is the comparative analysis of metabolite flux and how it relates to biological phenotypes. As an intermediate phenotype, metabolite signatures capture a unique aspect of cellular dynamics that is not typically interrogated, providing a distinct perspective on cellular homeostasis. To date, there have been only a few metabolomics studies investigating cardiovascular diseases. In this review, we explore the principles of metabolomics and how it can provide further insight into the mechanisms of cardiovascular physiology and ultimately lead to improved diagnostic and therapeutic options for patients with cardiovascular disease.

Original languageEnglish (US)
Pages (from-to)267-272
Number of pages6
JournalCurrent Atherosclerosis Reports
Volume12
Issue number4
DOIs
StatePublished - Jul 2010
Externally publishedYes

Fingerprint

Metabolomics
Atherosclerosis
Homeostasis
Cardiovascular Diseases
Cardiovascular Physiological Phenomena
Phenotype
Molecular Biology
Therapeutics

Keywords

  • Atherosclerosis
  • Bioinformatics
  • Biomarker
  • Coronary artery disease
  • Genomics
  • Left ventricular dysfunction
  • Mass spectrometry
  • Metabolite
  • Metabolomics
  • Nuclear magnetic resonance spectroscopy
  • Proteomics
  • Systems biology

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Metabolomics and atherosclerosis. / Goonewardena, Sascha N.; Prevette, Lisa E.; Desai, Ankit.

In: Current Atherosclerosis Reports, Vol. 12, No. 4, 07.2010, p. 267-272.

Research output: Contribution to journalArticle

Goonewardena, Sascha N. ; Prevette, Lisa E. ; Desai, Ankit. / Metabolomics and atherosclerosis. In: Current Atherosclerosis Reports. 2010 ; Vol. 12, No. 4. pp. 267-272.
@article{5230c1552cf64dbf9e22a8cf78d1c089,
title = "Metabolomics and atherosclerosis",
abstract = "Metabolites reflect the dynamic processes underlying cellular homeostasis. Recent advances in analytical chemistry and molecular biology have set the stage for metabolite profiling to help us understand complex molecular processes and physiology. Metabolomics is the comparative analysis of metabolite flux and how it relates to biological phenotypes. As an intermediate phenotype, metabolite signatures capture a unique aspect of cellular dynamics that is not typically interrogated, providing a distinct perspective on cellular homeostasis. To date, there have been only a few metabolomics studies investigating cardiovascular diseases. In this review, we explore the principles of metabolomics and how it can provide further insight into the mechanisms of cardiovascular physiology and ultimately lead to improved diagnostic and therapeutic options for patients with cardiovascular disease.",
keywords = "Atherosclerosis, Bioinformatics, Biomarker, Coronary artery disease, Genomics, Left ventricular dysfunction, Mass spectrometry, Metabolite, Metabolomics, Nuclear magnetic resonance spectroscopy, Proteomics, Systems biology",
author = "Goonewardena, {Sascha N.} and Prevette, {Lisa E.} and Ankit Desai",
year = "2010",
month = "7",
doi = "10.1007/s11883-010-0112-9",
language = "English (US)",
volume = "12",
pages = "267--272",
journal = "Current Atherosclerosis Reports",
issn = "1523-3804",
publisher = "Current Medicine Group",
number = "4",

}

TY - JOUR

T1 - Metabolomics and atherosclerosis

AU - Goonewardena, Sascha N.

AU - Prevette, Lisa E.

AU - Desai, Ankit

PY - 2010/7

Y1 - 2010/7

N2 - Metabolites reflect the dynamic processes underlying cellular homeostasis. Recent advances in analytical chemistry and molecular biology have set the stage for metabolite profiling to help us understand complex molecular processes and physiology. Metabolomics is the comparative analysis of metabolite flux and how it relates to biological phenotypes. As an intermediate phenotype, metabolite signatures capture a unique aspect of cellular dynamics that is not typically interrogated, providing a distinct perspective on cellular homeostasis. To date, there have been only a few metabolomics studies investigating cardiovascular diseases. In this review, we explore the principles of metabolomics and how it can provide further insight into the mechanisms of cardiovascular physiology and ultimately lead to improved diagnostic and therapeutic options for patients with cardiovascular disease.

AB - Metabolites reflect the dynamic processes underlying cellular homeostasis. Recent advances in analytical chemistry and molecular biology have set the stage for metabolite profiling to help us understand complex molecular processes and physiology. Metabolomics is the comparative analysis of metabolite flux and how it relates to biological phenotypes. As an intermediate phenotype, metabolite signatures capture a unique aspect of cellular dynamics that is not typically interrogated, providing a distinct perspective on cellular homeostasis. To date, there have been only a few metabolomics studies investigating cardiovascular diseases. In this review, we explore the principles of metabolomics and how it can provide further insight into the mechanisms of cardiovascular physiology and ultimately lead to improved diagnostic and therapeutic options for patients with cardiovascular disease.

KW - Atherosclerosis

KW - Bioinformatics

KW - Biomarker

KW - Coronary artery disease

KW - Genomics

KW - Left ventricular dysfunction

KW - Mass spectrometry

KW - Metabolite

KW - Metabolomics

KW - Nuclear magnetic resonance spectroscopy

KW - Proteomics

KW - Systems biology

UR - http://www.scopus.com/inward/record.url?scp=77955954825&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955954825&partnerID=8YFLogxK

U2 - 10.1007/s11883-010-0112-9

DO - 10.1007/s11883-010-0112-9

M3 - Article

VL - 12

SP - 267

EP - 272

JO - Current Atherosclerosis Reports

JF - Current Atherosclerosis Reports

SN - 1523-3804

IS - 4

ER -